tradmap

IMTX Immatics N.V.

$7.04 -2.09%

Data as of close

Healthcare · Biological Products, (No Diagnostic Substances)

Immatics N.V. (IMTX) is a healthcare company in the Biological Products, (No Diagnostic Substances) industry, with a market capitalization of $944 million. Shares last traded at $7.04, 43.3% below their 52-week high. Over the past year the stock is down 32.5%.

Market Cap
$944M
Shares Out
134.1M
EPS (TTM)
—
P/E (TTM)*
—
P/S Ratio
—
P/B Ratio
—
Dividend / Share
—
Dividend Yield
—
52-Week High
$12.41
52-Week Low
$6.65
Volume (venue)
111,872
Avg Vol (3m, venue)
54,723.524

* P/E (TTM) = market cap ÷ net income over the trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year — the same basis as the peer table and the screener, so it can differ from price ÷ EPS.

Immatics N.V. reports in EUR: EPS, dividends and financials are shown in EUR as filed. P/E, P/S, P/B and yield convert them at 1 EUR = 1.1163 USD on 2026-10-30 (Federal Reserve H.10 via FRED, DEXUSEU).

Performance

1W
-1.54%
1M
-7.37%
3M
-24.87%
6M
-36.83%
YTD
-32.95%
1Y
-32.50%

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)
39.07
SMA (50)
$8.21
SMA (200)
$9.58
Price vs SMA50
-14.26%
Price vs SMA200
-26.48%
ATR (14)
$0.40

Full technical analysis (26 indicators, D/W/M) →

Biological Products, (No Diagnostic Substances) peers

IMTX vs 14 industry peers (Biological Products, (No Diagnostic Substances)), by market cap. Data as of close

1–14 of 14
AMGNAmgen$251.7B28.786.6123.0%-0.13%
GILDGilead Sciences$211.3B—6.82-12.5%-0.23%
MRNAModerna$88.2B———-0.12%
RVMDRevolution Medicines, Inc.$40.4B———-1.58%
BIIBBiogen$36.8B105.923.573.4%-1.83%
EXELExelixis, Inc.$17.1B19.326.8535.5%+1.02%
NBIXNeurocrine Biosciences Inc$14.7B20.953.9819.0%-0.52%
HALOHalozyme Therapeutics, Inc.$14.6B35.388.8024.9%-1.50%
TECHBio-Techne$11.4B62.769.3915.0%-0.03%
RGENRepligen Corp$11.1B—13.73-1.5%-2.17%
QGENQiagen N.V.$10.9B25.705.2220.3%+0.33%
KYMRKymera Therapeutics, Inc.$10.9B———+0.68%
PCVXVaxcyte, Inc.$9.0B———-2.26%
KRYSKrystal Biotech, Inc.$8.8B38.9518.6647.9%-10.76%

Source: SEC EDGAR (fundamentals/EPS/dividends, reported in EUR) · Databento EQUS.MINI (prices) · FX: 1 EUR = 1.1163 USD on 2026-10-30 (Federal Reserve H.10 via FRED, DEXUSEU) · market cap & yield computed by tradmap. This product uses the FRED® API but is not endorsed or certified by the Federal Reserve Bank of St. Louis. Informational only — not financial advice.